Medicines Development for Global Health (MDGH) receives Ghana Food and Drugs Authority (FDA) approval for moxidectin, clearing the way for the planned community pilot treatment of river blindness.
Medicines Development for Global Health (MDGH) receives Ghana Food and Drugs Authority (FDA) approval for moxidectin, clearing the way for the planned community pilot treatment of river blindness.
